Clinical Trials Browser

Unknown × Colorectal Neoplasms × envafolimab × Clear all

NCT06060704 2023-10-11

Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT05551247 2022-09-22

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms